Articles By Jack Cush, MD
Outcomes of Critically-Ill COVID Patients in NYC
By Jack Cush, MD
21 May 2020
Lancet has reported COVID outcomes from NewYork-Presbyterian hospitals in NYC during March 2020 showing high rates of hospitalization, ICU admission, mechanical ventilation and death.
Read Article
No Certain Link between Biologics and Melanoma Risk
By Jack Cush, MD
21 May 2020
A review of available data fails to show an increased risk of melanoma in IMID (inflammatory bowel disease, rheumatoid arthritis, and psoriasis) patients treated with systemic biologic therapies.
Read Article
TNR - COVID-Rheumatology Registry & COVID in OZ
19 May 2020
This week's Tuesday Nite Rheumatology features presentations and interviews with Drs. Peter Nash and Philip Robinson. Dr. Robinson presents latest data on the Rheum-Covid.org Registry, that he helped establish under the Global Rheumatology Alliance. Dr. Nash presents the impact of COVID in Australia and pragmatic COVID management.
Read Article
Graduation
By Jack Cush, MD
19 May 2020
Congratulations! Years of training and work, all your efforts and overcoming hurdles have culminated in where you are today – on the verge of a new life, a new plan and possibly a new career.
Read Article
Systemic Sclerosis Future Therapies and Outcome Measures
By Jack Cush, MD
19 May 2020
Nagaraja, Khanna and colleagues have published an overview of current and future therapies in patients with systemic sclerosis (SSc) and have reviewed the potential outcome measures for this difficult autoimmune disorder.
Read Article
High Dose Anakinra Effective in COVID-19
By Jack Cush, MD
18 May 2020
Anakinra was studied in 29 COVID(+) patients with respiratory distress and high inflammatory markers (CRP or ferritin) and compared to non-anakinra patients, those on anakinra had better survival (90% vs. 56% ;p=0·009) and greater improvements in CRP and pulmonary function (72% vs 50%) compared to controls at day 21.
Read Article
RheumNow Podcast - COVID Kids and Men (5.15.20)
By Jack Cush, MD
15 May 2020
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.
Read Article
CDC on Pediatric Multi-System Inflammatory Syndrome
By Jack Cush, MD
14 May 2020
The latest hazardous spinoff to the coronavirus infection is an inflammatory, Kawasaki-like syndrome unique to children or adolescents with COVID-19. Sporadic reports from around the globe of this severe pediatric COVID syndrome have littered the news with brief mentions and little detail.
Read Article
Plaquenil Does Not Protect Lupus Patients from COVID-19
By Jack Cush, MD
14 May 2020
Annals of Rheumatic Disease reports on an analysis of lupus (SLE) patients that shows COVID-19 infection rates were similar between those lupus patients who were taking hydroxychloroquine (HCQ) and those not taking HCQ.
Read Article
TNR Grand Rounds - What does COVID-19 have to do with Lupus?
By Jack Cush, MD
13 May 2020
Last night's Tuesday Nite Rheumatology featured Dr. Joan Merrill (OMRF). In her lecture, "What does COVID-19 have to do with lupus?", she discusses the pathogenesis of lupus, and specifically thrombotic microangiopathy, complementopathies, catastrophic lupus syndrome and the potential overlap with the vascular pathology seen with COVID-19 infection.
Read Article